← Back to Search

Managing Cancer and Living Meaningfully (CALM) Therapy for Depression (CALM Trial)

N/A
Waitlist Available
Led By Ashlee Loughan, PhD
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Summary

The purpose of this study is to pilot test an empirically supported psychotherapeutic intervention, Managing Cancer and Living Meaningfully (CALM). Researchers hope to better understand the potential benefits of this intervention on brain tumor patients' mood and quality of life. This may lead to improvements in doctor's understanding of how to enhance brain tumor patient's wellbeing and overall functioning.

Eligible Conditions
  • Depression
  • Brain Metastases

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Completion of CALM Sessions
Follow-up Assessment Completion
Helpfulness of CALM Sessions
+7 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: TherapyExperimental Treatment1 Intervention
psychotherapeutic intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Managing Cancer and Living Meaningfully (CALM) Therapy
2020
N/A
~20

Find a Location

Who is running the clinical trial?

Virginia Commonwealth UniversityLead Sponsor
710 Previous Clinical Trials
22,886,923 Total Patients Enrolled
12 Trials studying Depression
6,502 Patients Enrolled for Depression
American Cancer Society, Inc.OTHER
226 Previous Clinical Trials
110,629 Total Patients Enrolled
7 Trials studying Depression
7,221 Patients Enrolled for Depression
Ashlee Loughan, PhDPrincipal InvestigatorVirginia Commonwealth University
4 Previous Clinical Trials
101 Total Patients Enrolled
~3 spots leftby Sep 2025